Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabidiol improves learning and memory deficits and alleviates anxiety in 12-month-old SAMP8 mice.

PloS one·2025
Same author

Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR).

The journal of nutrition, health & aging·2025
Same author

Gut microbiota disturbances in hospitalized older adults with malnutrition and clinical outcomes.

Nutrition (Burbank, Los Angeles County, Calif.)·2024
Same author

Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation.

The Journal of biological chemistry·2023
Same author

Low circulating adropin levels in late-middle aged African Americans with poor cognitive performance.

npj aging·2023
Same author

Anorexia of aging: An international assessment of healthcare providers' knowledge and practice gaps.

Journal of cachexia, sarcopenia and muscle·2023
Same journal

Universal-offer HIV testing amongst patients undergoing blood tests in primary care: results from a multi-centre study.

Family practice·2026
Same journal

Sustainable healthcare knowledge, experience and curricular perspectives: a cross-sectional survey within the European Young Family Doctors Movement network.

Family practice·2026
Same journal

General practice care models and satisfaction in Australian residential aged care homes: a national survey of GPs, practice nurses, and managers.

Family practice·2026
Same journal

Effect of direct access to physiotherapy on prescribing and imaging in primary care for musculoskeletal disorders: a systematic review and meta-analysis.

Family practice·2026
Same journal

Virtual and in-person interpretation: a qualitative study from the perspective of professional medical interpreters.

Family practice·2026
Same journal

Temporal changes in chronic disease management in primary care in relation to telehealth policy changes: Australian whole-of-population interrupted time-series analysis.

Family practice·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Sarcopenia in the elderly.

John E Morley1

  • 1Geriatric Research, Education and Clinical Center (GRECC), Veterans Affairs Medical Center and Department of Internal Medicine, Division of Geriatric Medicine, Saint Louis University School of Medicine, St Louis, MO, USA. morley@slu.edu

Family Practice
|March 9, 2012
PubMed
Summary
This summary is machine-generated.

Sarcopenia, the age-related loss of muscle, causes frailty and disability. Treatments include exercise, protein supplements, and emerging therapies like anabolic steroids and activin II receptor fusion proteins for muscle gain.

More Related Videos

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Related Experiment Videos

Last Updated: May 24, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Area of Science:

  • Gerontology
  • Muscle Physiology
  • Biomedical Science

Background:

  • Sarcopenia is characterized by the age-related decline in skeletal muscle mass and strength.
  • This condition significantly contributes to reduced physical function, frailty, and increased risk of disability in older adults.
  • Understanding the multifactorial causes of sarcopenia is crucial for developing effective interventions.

Purpose of the Study:

  • To summarize current and emerging therapeutic strategies for sarcopenia.
  • To highlight the potential of novel pharmacological agents in combating muscle loss.

Main Methods:

  • Review of existing literature on sarcopenia.
  • Analysis of current treatment protocols including exercise and nutritional interventions.
  • Evaluation of emerging treatments such as hormonal therapies and novel protein-based drugs.

Main Results:

  • Established treatments involve resistance exercise and leucine-enriched essential amino acid supplements.
  • Testosterone and anabolic steroids show emerging potential in managing sarcopenia.
  • An activin II receptor soluble fusion protein demonstrates significant promise for enhancing muscle mass and bone mineral density.

Conclusions:

  • Sarcopenia management requires a multi-pronged approach combining lifestyle interventions with pharmacological advancements.
  • Emerging therapies, particularly activin II receptor fusion proteins, offer promising avenues for effectively treating sarcopenia and improving patient outcomes.